Levels of Osteoporosis: Diagnosis, Management, Prevention

·

Share

The levels of osteoporosis are set by a bone density scan. A T-score of -1.0 or higher is normal, a score between -1.0 and -2.5 is low bone mass (osteopenia), -2.5 or lower is osteoporosis, and osteoporosis plus a fragility fracture is called severe or established osteoporosis. Each level calls for a different mix of diagnosis, management, and prevention. The right plan also depends on your overall fracture risk, not the score alone.

Osteoporosis weakens bone until it breaks under forces that a healthy skeleton would easily handle. In my practice, patients often come in holding a scan report and asking one question: “How bad is it?” This guide explains how the levels are defined and what each one means for treatment.

What Osteoporosis Is

Bone is living tissue that is constantly broken down by cells called osteoclasts and rebuilt by osteoblasts. This cycle is known as remodeling. Osteoporosis develops when breakdown outpaces rebuilding, leaving bone thinner, more porous, and more fragile inside.

Postmenopausal women are most affected, because the drop in estrogen speeds up bone loss. Men, younger people on certain medicines, and anyone with conditions affecting hormones or nutrient absorption can develop it too. It is often called a “silent” disease because bone loss causes no symptoms until a fracture happens.

The Levels of Osteoporosis Explained

Doctors grade bone health using the T-score, which compares your bone mineral density to that of a healthy young adult of the same sex. Each whole number is one standard deviation. A score of -2.5 means your bone density is 2.5 standard deviations below the young-adult average. For a patient-friendly walk-through, see our guide to T-scores.

Level T-score What it means
Normal -1.0 and above Bone density within the healthy young-adult range
Osteopenia (low bone mass) Between -1.0 and -2.5 Below normal but not yet osteoporosis; fracture risk varies widely
Osteoporosis -2.5 and below Bone density low enough to meet the diagnosis
Severe (established) osteoporosis -2.5 and below plus a fragility fracture Bone has already failed; highest risk of further fractures

One point matters a lot here. A person who breaks a hip or a vertebra from a minor fall is usually treated as having osteoporosis even if their T-score is only in the osteopenia range. The fracture shows the bone is fragile, whatever the number says.

For premenopausal women, men under 50, and children, doctors use the Z-score instead. It compares bone density with people of the same age. A Z-score of -2.0 or lower is described as “below the expected range for age” and prompts a search for an underlying cause.

How Osteoporosis Is Diagnosed

The standard test is dual-energy X-ray absorptiometry (DEXA or DXA). This quick, painless scan uses a very low dose of radiation to measure bone density at the lumbar spine and hip. The lowest score among these sites usually determines the level.

Diagnosis rarely stops at the scan. A complete assessment often includes:

  • Fracture risk calculation: tools such as FRAX combine age, sex, weight, prior fractures, family history, smoking, alcohol, steroid use, and bone density to estimate 10-year fracture risk.
  • Vertebral imaging: spine X-rays or vertebral fracture assessment on the DEXA machine can find compression fractures that caused no pain.
  • Blood tests: calcium, vitamin D, kidney and liver function, thyroid function, and sometimes testosterone, parathyroid hormone, or protein studies to rule out secondary causes, including myeloma.

Screening with DEXA is generally recommended for women from age 65 and for younger postmenopausal women or older men with risk factors.

Management at Each Level

Treatment is matched to fracture risk. The T-score level is a major part of that picture, but it isn’t the whole of it.

Level Typical management
Normal Prevention habits; repeat scanning only if risk factors change
Osteopenia Lifestyle measures, calcium and vitamin D; medication if calculated fracture risk is high
Osteoporosis Medication usually recommended, plus lifestyle measures and fall prevention
Severe osteoporosis Medication, often including bone-building (anabolic) drugs; fracture care and rehabilitation

Medications

Bisphosphonates such as alendronate, risedronate, and zoledronic acid slow osteoclast activity and are usually the first choice. Denosumab is an injection every six months that also blocks bone breakdown. It must not be stopped without a follow-on plan, because bone loss can rebound quickly. For the highest-risk patients, anabolic drugs such as teriparatide, abaloparatide, or romosozumab actively build new bone. Hormone therapy or raloxifene may suit selected postmenopausal women.

Lifestyle and fall prevention

Adults generally need around 1,000 to 1,200 mg of calcium a day, preferably from food, and adequate vitamin D. Weight-bearing and resistance exercise, balance training, stopping smoking, and limiting alcohol all support bone. Removing trip hazards at home and reviewing sedating medicines helps reduce falls, which is the other half of fracture prevention.

Procedures

Painful vertebral fractures that don’t settle may occasionally be treated with vertebroplasty or kyphoplasty, where bone cement stabilizes the collapsed vertebra. Hip fractures almost always need surgery.

Prevention: Keeping Bones at a Healthier Level

Prevention starts early. Most bone mass is built by the late twenties, so a good diet and activity in youth set a higher peak. Throughout adult life, the same habits slow the decline:

  • A diet with enough calcium, vitamin D, and protein
  • Regular weight-bearing activity such as walking, stair climbing, or dancing, plus strength training
  • No smoking and moderate alcohol intake
  • Discussing bone protection with your doctor if you take long-term steroids or other bone-thinning medicines
  • Timely screening if you are at higher risk

When to See a Doctor

See your doctor if you break a bone from a fall from standing height or less, lose more than a few centimeters of height, develop a stooped posture, or have sudden back pain without an obvious injury. These can all be signs of fragility fractures. It’s also worth asking about a DEXA scan if you are postmenopausal with risk factors, have had early menopause, or take long-term steroids.

Frequently Asked Questions

Can osteopenia turn into osteoporosis?

Yes, it can progress, especially without attention to risk factors. Many people with osteopenia stay stable for years, though, and some never need medication. Your fracture risk score, not the label alone, guides whether treatment is needed.

Can you move back up a level with treatment?

Treatment can raise bone density, and some people’s T-scores improve enough to cross back into the osteopenia range. The main goal is fewer fractures, and medications reduce fracture risk even when the score changes only modestly.

How often should a DEXA scan be repeated?

For people on treatment, repeat scans are commonly done every one to two years at first. For those with normal or mildly low density and no new risk factors, longer intervals are usually appropriate.

Is a T-score of -2.5 very serious?

It marks the threshold for diagnosing osteoporosis and signals a higher fracture risk. It is very treatable, and with medication, exercise, and fall prevention many people never go on to have a fracture.

Key Takeaways

  • The levels of osteoporosis run from normal to osteopenia, osteoporosis, and severe osteoporosis, based mainly on the DEXA T-score.
  • A fragility fracture changes the picture, whatever the score.
  • Management is guided by overall fracture risk and combines medication, nutrition, exercise, and fall prevention.
  • Prevention works at every level and is most powerful when started early.
Written by
Bone Marrow Biology, Haematology, Immunology
Contact [email protected] Dudakov_Lab Website Fred Hutchinson Cancer Research Center April 20, 2020 Cell death, innate signaling, and repair: Tale of a “dead-man’s switch” orchestrating tissue regeneration Dr. Dudakov graduated with a PhD in Immunology and Stem Cell Biology from Monash University in Australia, and completed a postdoctoral fellowship in the Immunology Program at Memorial Sloan Kettering Cancer Center in New…
View Full Profile →
Web Admin Avatar